As of Jun 5, 2025, the Brainsway stock's price-to-earnings ratio is 42.96. This results from the current EPS of $0.24 and stock price of $10.31. The PE ratio has decreased by 66% from the past four quarters average of 127.7.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 52.39 | N/A | $9.43 | $0.18 |
2023 | N/A | N/A | $6.48 | -$0.26 |
2022 | N/A | N/A | $2.47 | -$0.8 |
2021 | N/A | N/A | $7.7 | -$0.42 |
2020 | N/A | N/A | $7.54 | -$0.48 |
2019 | N/A | N/A | $9.75 | -$1 |
2018 | N/A | N/A | N/A | -$0.78 |
2017 | N/A | N/A | N/A | -$0.96 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 39.46 | -24.68% | $9.47 | $0.24 |
Dec 2024 | 52.39 | -54.64% | $9.43 | $0.18 |
Sep 2024 | 115.5 | -61.94% | $9.24 | $0.08 |
Jun 2024 | 303.5 | N/A | $6.07 | $0.02 |
Mar 2024 | N/A | N/A | $5.29 | -$0.12 |
Dec 2023 | N/A | N/A | $6.48 | -$0.26 |
Sep 2023 | N/A | N/A | $4.04 | -$0.48 |
Jun 2023 | N/A | N/A | $2.28 | -$0.76 |
Mar 2023 | N/A | N/A | $1.76 | -$0.8 |
Dec 2022 | N/A | N/A | $2.47 | -$0.8 |
Sep 2022 | N/A | N/A | $3.61 | -$0.62 |
Jun 2022 | N/A | N/A | $4.83 | -$0.42 |
Mar 2022 | N/A | N/A | $8.73 | -$0.4 |
Dec 2021 | N/A | N/A | $7.7 | -$0.42 |
Sep 2021 | N/A | N/A | $8.06 | -$0.36 |
Stock name | PE ratio | Market cap |
---|---|---|
BWAY Brainsway Ltd | 42.96 | $193.96M |
OBIO Orchestra BioMed Holdings Inc | N/A | $123.37M |
BWAY's price to earnings ratio is 42.96 as of Jun 5, 2025.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 5, 2025), Brainsway's stock price is $10.31. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.24. Therefore, Brainsway's PE ratio for today is 42.96. PE RATIO(42.96) = STOCK PRICE($10.31) / TTM EPS($0.24)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.